Filing Details

Accession Number:
0001209191-20-002631
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-08 20:49:55
Reporting Period:
2020-01-07
Accepted Time:
2020-01-08 20:49:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438533 Retrophin Inc. RTRX Pharmaceutical Preparations (2834) 262383102
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1763494 M Eric Dube 3721 Valley Centre Dr, #200
San Diego CA 92130
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-01-07 3,750 $13.94 46,250 No 4 S Direct
Common Stock Disposition 2020-01-08 3,750 $15.14 42,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.